Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction.

Mitochondrial calcium influx via MCU in dopaminergic neurons drives drug-specific dopamine release, enabling addiction behaviors without affecting natural rewards.

• Why it matters: Understanding the distinct bioenergetic pathways that facilitate drug addiction can lead to targeted therapies that avoid disrupting natural reward systems, addressing a critical gap in addiction treatment.
• What they did: The study used optogenetics, genetic deletion, and pharmacological inhibition to show that opioids and methamphetamine induce mitochondrial calcium influx through MCU in nucleus accumbens dopaminergic terminals, promoting ATP production during high neuronal activity.
• The result: Inhibiting MCU reduces drug-induced dopamine release and addictive behaviors while preserving natural reward responses, highlighting MCU as a promising therapeutic target for addiction intervention.